
FDA Approves Monjuvi for Relapsed & Refractory Follicular Lymphoma
The FDA approved Monjuvi (tafasitamab-cxix) plus rituximab and lenalidomide for adult patients with relapsed/refractory follicular lymphoma.

The FDA approved Monjuvi (tafasitamab-cxix) plus rituximab and lenalidomide for adult patients with relapsed/refractory follicular lymphoma.

A dual-targeting radiopharmaceutical therapy for cancer targets tumors through 177Lu-FAPI-RGD agents, showing 88.9% efficacy with minimal i…

Cambridge research highlights capsule sponge tests for esophageal cancer screening, offering Barrett's patients a less invasive alternative…

Can you get disability for sarcoidosis? Find out what it takes to qualify, what evidence you need, and how to make your strongest case for …

Find out if you can get life insurance if you have Crohn's disease, what to expect, and how to improve your chances of getting affordable c…

New treatments for myositis offer hope and better outcomes. Get the latest on therapies, risks, and living well with this rare autoimmune d…

Find out how to get life insurance with multiple sclerosis. See your options, tips for approval, and compare costs—even with a high-risk MS…

Feeling tired or foggy? The intrinsic factor antibody test could reveal if your body absorbs vitamin B12 properly. Get the facts, symptoms,…

Myasthenia gravis history, symptoms, diagnosis, and treatments explained in a real, relatable way. Find hope and support on your autoimmune…

The diagnosis code for rheumatoid arthritis helps guide treatment, insurance, and care. Find out how it impacts your RA journey and what yo…

Autoimmune small fiber neuropathy can cause persistent tingling and pain. Find out what triggers it, symptoms, and how to get real answers …

Autoimmune disease after cancer treatment can be confusing. Find out why it happens, common symptoms, and how to manage your health and rec…
General information only — not medical advice. Always consult a qualified healthcare professional about your own situation.